Bayer sues Abbott for US Humira royalties
This article was originally published in Scrip
Executive Summary
BayerHealthcare has filed a US patent infringement lawsuit againstAbbott, and has demanded royalties on Abbott's anti-TNF product Humira (adalimumab). Abbott has been marketing the autoimmune product in the US since 2003.